imiquimod has been researched along with Vitiligo in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (38.10) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Cen, J; Cheng, H; Lin, X; Seifert, O; Yu, H | 1 |
Piqué-Duran, E | 1 |
Grimes, PE; Nashawati, R | 1 |
Huang, Z; Lü, T; Miao, F; Shi, L; Wang, HW; Wang, XL | 1 |
Eby, JM; Hariharan, V; Hernandez, C; Le Poole, IC; Luiten, RM; Webb, KC | 1 |
Cao, W; Ge, L; Li, W; Song, H; Xin, H | 1 |
Boniface, K; Ezzedine, K; Seneschal, J; Taieb, A | 1 |
Kawada, A; Narita, T; Oiso, N | 1 |
de Troya Martín, M; Fernández Morano, MT; García-Montero, P; Repiso Jiménez, JB | 1 |
Long, FQ; Qian, YH; Zhao, LS | 1 |
Fitzpatrick, JE; Gaspari, AA; Goldenberg, G; Gowda, S; Tillman, DK | 1 |
Godbolt, A; Sriprakash, K | 1 |
Ahn, JH; Hwang, HS; Kang, HY; Kang, SU; Kim, CH; Lee, MH; Pyun, JH | 1 |
Burnett, CT; Kouba, DJ | 1 |
Urbina, F | 1 |
Sidbury, R | 1 |
Bong, AB; Gollnick, H; Schön, MP | 1 |
Antoniou, C; Hadjivassiliou, M; Katsambas, A; Nicolaidou, E; Stefanaki, C | 1 |
Bendandi, M; del Olmo, J; Inoges, S; López-Diaz de Cerio, A; Marquina, M; Melero, I; Redondo, P | 1 |
Al-Dujaili, Z; Hsu, S | 1 |
Brenner, S; Mashiah, J | 1 |
5 review(s) available for imiquimod and Vitiligo
Article | Year |
---|---|
Depigmentation Therapies for Vitiligo.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anisoles; Body Surface Area; Cryotherapy; Cyclopropanes; Humans; Hydroquinones; Imatinib Mesylate; Imiquimod; Low-Level Light Therapy; Patient Selection; Phenol; Protein Kinase Inhibitors; Severity of Illness Index; Skin Lightening Preparations; Vitiligo | 2017 |
Accelerating bleaching in vitiligo: balancing benefits versus risks.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Humans; Hydroquinones; Imiquimod; Melanocytes; Risk Assessment; Skin Lightening Preparations; Vitiligo | 2014 |
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Hypopigmentation; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Vitiligo | 2009 |
Imiquimod-induced depigmentation: report of two cases and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Skin Neoplasms; Vitiligo | 2012 |
What's new in pediatric dermatology: update for the pediatrician.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Clinical Trials as Topic; Dermatitis, Atopic; Hemangioma; Humans; Imiquimod; Immunoglobulins; Immunologic Factors; Immunosuppressive Agents; Infant; Molluscum Contagiosum; Skin; Skin Diseases; Stevens-Johnson Syndrome; Tacrolimus; Vitiligo; Warts | 2004 |
16 other study(ies) available for imiquimod and Vitiligo
Article | Year |
---|---|
Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function.
Topics: Apoptosis; Humans; Imiquimod; Melanins; Melanocytes; Vitiligo | 2022 |
Recurrence of a Basal Cell Carcinoma in a Vitiligo-like Area After Imiquimod Treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vitiligo | 2021 |
Imiquimod-induced localized vitiligo in wife and lichen planus in husband.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Female; Humans; Imiquimod; Lichen Planus; Male; Vitiligo | 2013 |
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
Topics: Aminoquinolines; Apoptosis; Chemotherapy, Adjuvant; Drug Therapy, Combination; HSP70 Heat-Shock Proteins; Humans; Hydroquinones; Imiquimod; Immunotherapy; Melanocytes; Oligodeoxyribonucleotides; Skin Lightening Preparations; Toll-Like Receptors; Treatment Outcome; Vitiligo | 2014 |
Induction of vitiligo after imiquimod treatment of condylomata acuminata.
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Vitiligo | 2014 |
Imiquimod-induced vitiligo-like depigmentation over multiple solar keratosis in a patient with vitiligo.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Keratosis, Actinic; Male; Vitiligo | 2017 |
Genital Vitiligo-like Hypopigmentation After Treatment With 5% Imiquimod.
Topics: Adult; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Vitiligo; Vulvar Diseases | 2017 |
Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Vitiligo | 2017 |
Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Melanocytes; Skin; Skin Neoplasms; Time Factors; Vitiligo | 2009 |
Imiquimod induces apoptosis of human melanocytes.
Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Caspase 3; Cells, Cultured; Humans; Hypopigmentation; Imiquimod; In Situ Nick-End Labeling; Melanocytes; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Vitiligo | 2010 |
Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Head and Neck Neoplasms; Humans; Imiquimod; Scalp; Skin Neoplasms; Vitiligo | 2012 |
Treatment of vitiligo with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Treatment Outcome; Vitiligo | 2004 |
Imiquimod-induced vitiligo in a patient with genital warts.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Penile Diseases; Penis; Vitiligo | 2006 |
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Antigens, Neoplasm; Combined Modality Therapy; Cryosurgery; Female; Imiquimod; Immunity; Interferon Inducers; Interferon-gamma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Skin Neoplasms; Toll-Like Receptor 7; Vitiligo | 2007 |
Imiquimod-induced vitiligo.
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Genital Diseases, Male; Humans; Imiquimod; Male; Risk Assessment; Vitiligo | 2007 |
Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Vitiligo | 2008 |